☆ 4.3 Article

Management Strategies for Relapsed/Refractory Multiple Myeloma: Current Clinical Perspectives

SEMINARS IN HEMATOLOGY (2012)

Get Full Text
Add to Collection

Journal

SEMINARS IN HEMATOLOGY
Volume 49, Issue 3, Pages S16-S32

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.seminhematol.2012.05.003

Keywords

-

Categories

Hematology

Funding

  1. Bristol-Myers Squibb
  2. Celgene
  3. Millennium Pharmaceuticals
  4. Onyx Pharmacetuicals
  5. Onyx Pharmaceuticals

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.